首页> 美国卫生研究院文献>other >PATH-41. PLASMA CELL-FREE DNA (cfDNA) CONCENTRATION IS INDEPENDENTLY ASSOCIATED WITH RADIOGRAPHIC TUMOR BURDEN IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PRIOR TO INITIAL SURGICAL RESECTION
【2h】

PATH-41. PLASMA CELL-FREE DNA (cfDNA) CONCENTRATION IS INDEPENDENTLY ASSOCIATED WITH RADIOGRAPHIC TUMOR BURDEN IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PRIOR TO INITIAL SURGICAL RESECTION

机译:路径41。在首次手术切除之前新诊断的胶质母细胞瘤(GBM)中血浆无细胞DNA(cfDNA)的浓度与放射线照相的肿瘤无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDDistinguishing between radiographic pseudoprogression and true tumor progression is challenging in patients with GBM. Recent data suggests that plasma cfDNA concentration may serve as a viable surrogate for tumor burden in other malignancies. We performed a pilot study to determine the feasibility of detecting cfDNA in patients with newly diagnosed GBM and explored its correlation with radiographic tumor burden and other relevant clinical variables.
机译:背景技术在GBM患者中区分放射照相的伪进展和真实的肿瘤进展是具有挑战性的。最近的数据表明血浆cfDNA浓度可以作为其他恶性肿瘤中肿瘤负担的可行替代指标。我们进行了一项初步研究,以确定在新诊断的GBM患者中检测cfDNA的可行性,并探讨了其与放射线照相肿瘤负荷和其他相关临床变量的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号